Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial

被引:9
|
作者
Wang Z. [1 ,2 ]
Wang R. [3 ]
Xiang S. [3 ]
Gu Y. [4 ]
Xu T. [3 ]
Jin H. [3 ]
Gu X. [3 ]
Tong P. [5 ]
Zhan H. [1 ,2 ]
Lv S. [5 ]
机构
[1] Shi’s Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai
[2] Institute of Traumatology and Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai
[3] Zhejiang Chinese Medical University, Zhejiang, Hangzhou
[4] Zhangjiagang TCM Hospital, Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu
[5] The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang, Hangzhou
关键词
hyaluronic acid; intra-articular injection; knee; osteoarthritis; platelet-rich plasma;
D O I
10.3389/fbioe.2022.1062371
中图分类号
学科分类号
摘要
Background: Knee osteoarthritis (KOA) can be effectively treated conservatively using platelet-rich plasma (PRP) injections into the affected joints. While the short-term therapeutic clinical benefits were well documented, the mid-term results remain undetermined. To clarify its efficacy, the mid-term clinical outcomes of intra-articular injections of either PRP or hyaluronic acid (HA) in KOA were compared. Methods: One hundred patients who complied with the inclusion criteria were randomized to undergo once a week 3 weeks, intra-articular injections of either PRP or HA. Patients were evaluated before the injection, at 3, 6, and a mean of 78.9 months of follow-up. Eighty-five patients reached the final evaluation. Data on survival, re-intervention, pain, function, imaging, and satisfaction were collected and analyzed. Results: With surgery for any reason as the endpoint, the cumulative survival rate of the PRP group was 90%, while that of the HA group was 74%. There was a significant difference between the two groups in the total re-intervention rate (56.7% vs 16.2%, p < 0.05). The comparative analyses showed significant intergroup differences in the visual analog scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (p < 0.01, p < 0.05, respectively) at the final follow-up. And base on the regression analyses, the type of treatment, age, and Kellgren-Lawrence (K-L) grade served as statistically an independent determinants of VAS (p < 0.001, p = 0.034, p < 0.001, respectively). Likewise, those variables independently determined WOMAC in our study. However, no difference was observed in the imaging evaluation, containing the K-L grade and Cartilage Lesion Score, between the two groups (p > 0.05). Besides, the satisfaction treated by the PRP was 78.6%, with a superiority compared with HA (55.8%, p < 0.05), and no complications were noted in the whole treatment process among patients who participated. Conclusion: PRP was more effective than HA in survival and re-intervention rates, VAS, and WOMAC, although there were no significant differences in the imaging evaluation between the two groups. Furthermore, patients treated with PRP were associated with higher satisfaction compared with HA. Copyright © 2022 Wang, Wang, Xiang, Gu, Xu, Jin, Gu, Tong, Zhan and Lv.
引用
收藏
相关论文
共 50 条
  • [21] Comparative Analysis of the Effectiveness of Intra-articular Injection of Platelet-Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: Results of an Open-Label Trial
    Jivan, Sara Jalali
    Monzavi, Seyed Mostala
    Zargaran, Bita
    Alamdari, Daryoush Hamidi
    Afshari, Jalil Tavakol
    Etemad-Rezaie, Ali
    Sakhmaresi, Tayebeh Asadi
    Shariati-Sarabi, Zhaleh
    ARCHIVES OF BONE AND JOINT SURGERY-ABJS, 2021, 9 (05): : 487 - 495
  • [22] Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial
    Giuseppe Filardo
    Elizaveta Kon
    Alessandro Di Martino
    Berardo Di Matteo
    Maria Letizia Merli
    Annarita Cenacchi
    Pier Maria Fornasari
    Maurilio Marcacci
    BMC Musculoskeletal Disorders, 13
  • [23] Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial
    Filardo, Giuseppe
    Kon, Elizaveta
    Di Martino, Alessandro
    Di Matteo, Berardo
    Merli, Maria Letizia
    Cenacchi, Annarita
    Fornasari, Pier Maria
    Marcacci, Maurilio
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [24] Multiple Injections of Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Current Evidence in Randomized Controlled Trials
    Li, Shang
    Xing, Fei
    Yan, Tongtong
    Zhang, Siya
    Chen, Fengchao
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [25] Intra-articular injections of platelet-rich plasma vs. hyaluronic acid in patients with knee osteoarthritis: Preliminary follow-up results at 6-months
    Li, Ming
    Huang, Zheyu
    Wang, Shicheng
    Di, Zhenglin
    Zhang, Junhui
    Liu, Hua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [26] Efficacy of a Novel Intra-Articular Administration of Platelet-Rich Plasma One-Week Prior to Hyaluronic Acid versus Platelet-Rich Plasma Alone in Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Controlled Trial
    Wu, Yung-Tsan
    Li, Tsung-Ying
    Lee, Kuei-Chen
    Lam, King Hei Stanley
    Chang, Chih-Ya
    Chang, Cheng-Kuang
    Chen, Liang-Cheng
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [27] Clinical Efficacy of Platelet-Rich Plasma Injection and Its Association With Growth Factors in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized Double-Blind Controlled Clinical Trial As Compared With Hyaluronic Acid
    Park, Yong-Beom
    Kim, Jun-Ho
    Ha, Chul-Won
    Lee, Dong-Hyun
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2021, 49 (02): : 487 - 496
  • [28] Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) Versus Hyaluronic Acid (A one-year randomized clinical trial)
    Raeissadat, Seyed Ahmad
    Rayegani, Seyed Mansoor
    Hassanabadi, Hossein
    Fathi, Mohammad
    Ghorbani, Elham
    Babaee, Marzieh
    Azma, Kamran
    CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2015, 8 : 1 - 8
  • [29] Intra-articular injection of Platelet rich plasma versus Hyaluronic acid for moderate knee osteoarthritis. A prospective, double-blind randomized controlled trial on 189 patients with follow-up for three years
    Deek, Medhat S.
    Abry, Dina S.
    El Seedek, Hisham
    Arweash, Ahmed
    ACTA ORTHOPAEDICA BELGICA, 2021, 87 (04): : 729 - 734
  • [30] ASSESSMENT OF THE RESPONSE PROFILE TO HYALURONIC ACID PLUS SORBITOL INJECTION IN PATIENTS WITH KNEE OSTEOARTHRITIS: POST HOC ANALYSIS OF A 6-MONTH RANDOMIZED CONTROLLED TRIAL
    Bruyere, O.
    Honvo, G.
    Vidovic, E.
    Cortet, B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S229 - S229